tdp 43 Search Results


91
Novus Biologicals c terminus region
C Terminus Region, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tdp+43/TDP-43%2FTARDBP+Antibody+-+BSA+Free/pm25630387-266-31-36
Average 91 stars, based on 1 article reviews
c terminus region - by Bioz Stars, 2026-11
91/100 stars
  Buy from Supplier

95
Proteintech tdp 43
Tdp 43, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tdp+43/TDP-43+(C-terminal)+Antibody/pmc06155127-248-59-61
Average 95 stars, based on 1 article reviews
tdp 43 - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

96
Proteintech protein 43 antisera tdp 43
Protein 43 Antisera Tdp 43, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tdp+43/TDP-43+(for+IF%2FFC)+Antibody/pm17923627-40-56-60
Average 96 stars, based on 1 article reviews
protein 43 antisera tdp 43 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

94
Proteintech mouse anti tdp 43
Mouse Anti Tdp 43, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tdp+43/TDP-43+(human+specific)+Antibody/pmc10361247-480-94-97
Average 94 stars, based on 1 article reviews
mouse anti tdp 43 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
Proteintech tardbp
hUBQLN2 co-localized <t>with</t> <t>TDP-43</t> and P62 but not with NF-κB and IκB-α. Immunofluorescence of Neuro2A cells at 48 h after transfection with ( a ) control plasmid, ( b ) pCMV-hUBQLN2 WT and ( c ) pCMV-hUBQLN2 P497H . <t>Indicated</t> <t>antibodies</t> were used according to Materials and Methods. Microscopy pictures were taken at 63× magnification. d - e Western analysis from three repeated experiments was used for quantification of ( d ) TDP-43 level ( p = 0.0227 for hUBQLN2 WT and p = 0.0032 for hUBQLN2 P497H ) and ( e ) p62 level ( p = 0.0058 for hUBQLN2 WT and p = 0.0130 for hUBQLN2 P497H ) in insoluble fraction. Results were calculated in fold change compared to proteins level in insoluble fraction of control cells. f Neuro2A cells were transfected with control plasmid, pCMV-hUBQLN2 WT or pCMV-hUBQLN2 P497H . Cells were extracted 48 h after transfection using aggregates assay protocol. The results suggested that overexpression of UBQLN2 species increased levels of UBQLN2, TDP-43 and p62 in the insoluble fraction. g Live imaging was performed on Neuro2A pFeGFP-hUBQLN2 P497H and DsRED-TDP-43 co-transfected cells. Microscopy pictures were taken at 24 and 48 h after transfection. h Immunoblot of TDP-43 in cytoplasmic (C) vs nuclear (N) after transfection with control plasmid, pCMV-hUBQLN2 WT or pCMV-hUBQLN2 P497H plasmids. i HEK293 cells and Neuro2A cells were transfected with either control plasmid or pCMV-hUBQLN2 P497H plasmid. Protein levels of hUBQLN2 and mUBQLN2 were measured at 48 h after transfection. Human UBQLN2 levels were similar in control HEK293 and pCMV-hUBQLN2 P497H Neuro2A transfected cells. Scale bar = 25 μm
Tardbp, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tdp+43/TDP-43+Antibody/pmc04628361-274-9-10
Average 94 stars, based on 1 article reviews
tardbp - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

96
Proteintech room temperature rt
hUBQLN2 co-localized <t>with</t> <t>TDP-43</t> and P62 but not with NF-κB and IκB-α. Immunofluorescence of Neuro2A cells at 48 h after transfection with ( a ) control plasmid, ( b ) pCMV-hUBQLN2 WT and ( c ) pCMV-hUBQLN2 P497H . <t>Indicated</t> <t>antibodies</t> were used according to Materials and Methods. Microscopy pictures were taken at 63× magnification. d - e Western analysis from three repeated experiments was used for quantification of ( d ) TDP-43 level ( p = 0.0227 for hUBQLN2 WT and p = 0.0032 for hUBQLN2 P497H ) and ( e ) p62 level ( p = 0.0058 for hUBQLN2 WT and p = 0.0130 for hUBQLN2 P497H ) in insoluble fraction. Results were calculated in fold change compared to proteins level in insoluble fraction of control cells. f Neuro2A cells were transfected with control plasmid, pCMV-hUBQLN2 WT or pCMV-hUBQLN2 P497H . Cells were extracted 48 h after transfection using aggregates assay protocol. The results suggested that overexpression of UBQLN2 species increased levels of UBQLN2, TDP-43 and p62 in the insoluble fraction. g Live imaging was performed on Neuro2A pFeGFP-hUBQLN2 P497H and DsRED-TDP-43 co-transfected cells. Microscopy pictures were taken at 24 and 48 h after transfection. h Immunoblot of TDP-43 in cytoplasmic (C) vs nuclear (N) after transfection with control plasmid, pCMV-hUBQLN2 WT or pCMV-hUBQLN2 P497H plasmids. i HEK293 cells and Neuro2A cells were transfected with either control plasmid or pCMV-hUBQLN2 P497H plasmid. Protein levels of hUBQLN2 and mUBQLN2 were measured at 48 h after transfection. Human UBQLN2 levels were similar in control HEK293 and pCMV-hUBQLN2 P497H Neuro2A transfected cells. Scale bar = 25 μm
Room Temperature Rt, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tdp+43/TDP-43+Polyclonal+antibody/pmc12826566-75-15-29
Average 96 stars, based on 1 article reviews
room temperature rt - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

92
R&D Systems mab77782
hUBQLN2 co-localized <t>with</t> <t>TDP-43</t> and P62 but not with NF-κB and IκB-α. Immunofluorescence of Neuro2A cells at 48 h after transfection with ( a ) control plasmid, ( b ) pCMV-hUBQLN2 WT and ( c ) pCMV-hUBQLN2 P497H . <t>Indicated</t> <t>antibodies</t> were used according to Materials and Methods. Microscopy pictures were taken at 63× magnification. d - e Western analysis from three repeated experiments was used for quantification of ( d ) TDP-43 level ( p = 0.0227 for hUBQLN2 WT and p = 0.0032 for hUBQLN2 P497H ) and ( e ) p62 level ( p = 0.0058 for hUBQLN2 WT and p = 0.0130 for hUBQLN2 P497H ) in insoluble fraction. Results were calculated in fold change compared to proteins level in insoluble fraction of control cells. f Neuro2A cells were transfected with control plasmid, pCMV-hUBQLN2 WT or pCMV-hUBQLN2 P497H . Cells were extracted 48 h after transfection using aggregates assay protocol. The results suggested that overexpression of UBQLN2 species increased levels of UBQLN2, TDP-43 and p62 in the insoluble fraction. g Live imaging was performed on Neuro2A pFeGFP-hUBQLN2 P497H and DsRED-TDP-43 co-transfected cells. Microscopy pictures were taken at 24 and 48 h after transfection. h Immunoblot of TDP-43 in cytoplasmic (C) vs nuclear (N) after transfection with control plasmid, pCMV-hUBQLN2 WT or pCMV-hUBQLN2 P497H plasmids. i HEK293 cells and Neuro2A cells were transfected with either control plasmid or pCMV-hUBQLN2 P497H plasmid. Protein levels of hUBQLN2 and mUBQLN2 were measured at 48 h after transfection. Human UBQLN2 levels were similar in control HEK293 and pCMV-hUBQLN2 P497H Neuro2A transfected cells. Scale bar = 25 μm
Mab77782, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tdp+43/Human+TDP-43%2FTARDBP+Antibody/pm35501375-48-23-24
Average 92 stars, based on 1 article reviews
mab77782 - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

90
OriGene human tdp 43
hUBQLN2 co-localized <t>with</t> <t>TDP-43</t> and P62 but not with NF-κB and IκB-α. Immunofluorescence of Neuro2A cells at 48 h after transfection with ( a ) control plasmid, ( b ) pCMV-hUBQLN2 WT and ( c ) pCMV-hUBQLN2 P497H . <t>Indicated</t> <t>antibodies</t> were used according to Materials and Methods. Microscopy pictures were taken at 63× magnification. d - e Western analysis from three repeated experiments was used for quantification of ( d ) TDP-43 level ( p = 0.0227 for hUBQLN2 WT and p = 0.0032 for hUBQLN2 P497H ) and ( e ) p62 level ( p = 0.0058 for hUBQLN2 WT and p = 0.0130 for hUBQLN2 P497H ) in insoluble fraction. Results were calculated in fold change compared to proteins level in insoluble fraction of control cells. f Neuro2A cells were transfected with control plasmid, pCMV-hUBQLN2 WT or pCMV-hUBQLN2 P497H . Cells were extracted 48 h after transfection using aggregates assay protocol. The results suggested that overexpression of UBQLN2 species increased levels of UBQLN2, TDP-43 and p62 in the insoluble fraction. g Live imaging was performed on Neuro2A pFeGFP-hUBQLN2 P497H and DsRED-TDP-43 co-transfected cells. Microscopy pictures were taken at 24 and 48 h after transfection. h Immunoblot of TDP-43 in cytoplasmic (C) vs nuclear (N) after transfection with control plasmid, pCMV-hUBQLN2 WT or pCMV-hUBQLN2 P497H plasmids. i HEK293 cells and Neuro2A cells were transfected with either control plasmid or pCMV-hUBQLN2 P497H plasmid. Protein levels of hUBQLN2 and mUBQLN2 were measured at 48 h after transfection. Human UBQLN2 levels were similar in control HEK293 and pCMV-hUBQLN2 P497H Neuro2A transfected cells. Scale bar = 25 μm
Human Tdp 43, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tdp+43/TDP43+(TARDBP)+(NM_007375)+Human+Tagged+ORF+Clone/pmc07705063-34-24-29
Average 90 stars, based on 1 article reviews
human tdp 43 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

93
Addgene inc tdp 43 ctd plasmid
hUBQLN2 co-localized <t>with</t> <t>TDP-43</t> and P62 but not with NF-κB and IκB-α. Immunofluorescence of Neuro2A cells at 48 h after transfection with ( a ) control plasmid, ( b ) pCMV-hUBQLN2 WT and ( c ) pCMV-hUBQLN2 P497H . <t>Indicated</t> <t>antibodies</t> were used according to Materials and Methods. Microscopy pictures were taken at 63× magnification. d - e Western analysis from three repeated experiments was used for quantification of ( d ) TDP-43 level ( p = 0.0227 for hUBQLN2 WT and p = 0.0032 for hUBQLN2 P497H ) and ( e ) p62 level ( p = 0.0058 for hUBQLN2 WT and p = 0.0130 for hUBQLN2 P497H ) in insoluble fraction. Results were calculated in fold change compared to proteins level in insoluble fraction of control cells. f Neuro2A cells were transfected with control plasmid, pCMV-hUBQLN2 WT or pCMV-hUBQLN2 P497H . Cells were extracted 48 h after transfection using aggregates assay protocol. The results suggested that overexpression of UBQLN2 species increased levels of UBQLN2, TDP-43 and p62 in the insoluble fraction. g Live imaging was performed on Neuro2A pFeGFP-hUBQLN2 P497H and DsRED-TDP-43 co-transfected cells. Microscopy pictures were taken at 24 and 48 h after transfection. h Immunoblot of TDP-43 in cytoplasmic (C) vs nuclear (N) after transfection with control plasmid, pCMV-hUBQLN2 WT or pCMV-hUBQLN2 P497H plasmids. i HEK293 cells and Neuro2A cells were transfected with either control plasmid or pCMV-hUBQLN2 P497H plasmid. Protein levels of hUBQLN2 and mUBQLN2 were measured at 48 h after transfection. Human UBQLN2 levels were similar in control HEK293 and pCMV-hUBQLN2 P497H Neuro2A transfected cells. Scale bar = 25 μm
Tdp 43 Ctd Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tdp+43/TDP-43_CTD+(Plasmid+%2398669)/pmc08784639-94-0-9
Average 93 stars, based on 1 article reviews
tdp 43 ctd plasmid - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

94
Proteintech human tdp 43 elisa kit
hUBQLN2 co-localized <t>with</t> <t>TDP-43</t> and P62 but not with NF-κB and IκB-α. Immunofluorescence of Neuro2A cells at 48 h after transfection with ( a ) control plasmid, ( b ) pCMV-hUBQLN2 WT and ( c ) pCMV-hUBQLN2 P497H . <t>Indicated</t> <t>antibodies</t> were used according to Materials and Methods. Microscopy pictures were taken at 63× magnification. d - e Western analysis from three repeated experiments was used for quantification of ( d ) TDP-43 level ( p = 0.0227 for hUBQLN2 WT and p = 0.0032 for hUBQLN2 P497H ) and ( e ) p62 level ( p = 0.0058 for hUBQLN2 WT and p = 0.0130 for hUBQLN2 P497H ) in insoluble fraction. Results were calculated in fold change compared to proteins level in insoluble fraction of control cells. f Neuro2A cells were transfected with control plasmid, pCMV-hUBQLN2 WT or pCMV-hUBQLN2 P497H . Cells were extracted 48 h after transfection using aggregates assay protocol. The results suggested that overexpression of UBQLN2 species increased levels of UBQLN2, TDP-43 and p62 in the insoluble fraction. g Live imaging was performed on Neuro2A pFeGFP-hUBQLN2 P497H and DsRED-TDP-43 co-transfected cells. Microscopy pictures were taken at 24 and 48 h after transfection. h Immunoblot of TDP-43 in cytoplasmic (C) vs nuclear (N) after transfection with control plasmid, pCMV-hUBQLN2 WT or pCMV-hUBQLN2 P497H plasmids. i HEK293 cells and Neuro2A cells were transfected with either control plasmid or pCMV-hUBQLN2 P497H plasmid. Protein levels of hUBQLN2 and mUBQLN2 were measured at 48 h after transfection. Human UBQLN2 levels were similar in control HEK293 and pCMV-hUBQLN2 P497H Neuro2A transfected cells. Scale bar = 25 μm
Human Tdp 43 Elisa Kit, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tdp+43/Human+TDP-43+ELISA+Kit/pmc12667529-195-8-12
Average 94 stars, based on 1 article reviews
human tdp 43 elisa kit - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
ABclonal Biotechnology tdp 43
(A) Schematic of the overall design of the study. (B-C) Genomic location profiling <t>of</t> <t>TDP-43</t> and dG4 in K562 and HepG2 cell lines. (D-E) Genomic location profiling of sites with TDP-43 and dG4 co-occupancy. (F) Overlap of genes with promoter TDP-43 binding and genes with promoter dG4 formation in K562 and HepG2 cells. (G-H) Genome browser view of dG4 and TDP-43 signals across the promoters of TAL1 in K562 cells, and DBF4 in HepG2 cells.
Tdp 43, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tdp+43/TARDBP+Rabbit+pAb/bio_rxiv__64898__2026__05__13__724493-110-8-9
Average 94 stars, based on 1 article reviews
tdp 43 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
Novus Biologicals mouse anti tardbp
(A) Schematic of the overall design of the study. (B-C) Genomic location profiling <t>of</t> <t>TDP-43</t> and dG4 in K562 and HepG2 cell lines. (D-E) Genomic location profiling of sites with TDP-43 and dG4 co-occupancy. (F) Overlap of genes with promoter TDP-43 binding and genes with promoter dG4 formation in K562 and HepG2 cells. (G-H) Genome browser view of dG4 and TDP-43 signals across the promoters of TAL1 in K562 cells, and DBF4 in HepG2 cells.
Mouse Anti Tardbp, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tdp+43/TDP-43%2FTARDBP+Antibody+(3H8)/pmc12427303-93-34-38
Average 93 stars, based on 1 article reviews
mouse anti tardbp - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

Image Search Results


hUBQLN2 co-localized with TDP-43 and P62 but not with NF-κB and IκB-α. Immunofluorescence of Neuro2A cells at 48 h after transfection with ( a ) control plasmid, ( b ) pCMV-hUBQLN2 WT and ( c ) pCMV-hUBQLN2 P497H . Indicated antibodies were used according to Materials and Methods. Microscopy pictures were taken at 63× magnification. d - e Western analysis from three repeated experiments was used for quantification of ( d ) TDP-43 level ( p = 0.0227 for hUBQLN2 WT and p = 0.0032 for hUBQLN2 P497H ) and ( e ) p62 level ( p = 0.0058 for hUBQLN2 WT and p = 0.0130 for hUBQLN2 P497H ) in insoluble fraction. Results were calculated in fold change compared to proteins level in insoluble fraction of control cells. f Neuro2A cells were transfected with control plasmid, pCMV-hUBQLN2 WT or pCMV-hUBQLN2 P497H . Cells were extracted 48 h after transfection using aggregates assay protocol. The results suggested that overexpression of UBQLN2 species increased levels of UBQLN2, TDP-43 and p62 in the insoluble fraction. g Live imaging was performed on Neuro2A pFeGFP-hUBQLN2 P497H and DsRED-TDP-43 co-transfected cells. Microscopy pictures were taken at 24 and 48 h after transfection. h Immunoblot of TDP-43 in cytoplasmic (C) vs nuclear (N) after transfection with control plasmid, pCMV-hUBQLN2 WT or pCMV-hUBQLN2 P497H plasmids. i HEK293 cells and Neuro2A cells were transfected with either control plasmid or pCMV-hUBQLN2 P497H plasmid. Protein levels of hUBQLN2 and mUBQLN2 were measured at 48 h after transfection. Human UBQLN2 levels were similar in control HEK293 and pCMV-hUBQLN2 P497H Neuro2A transfected cells. Scale bar = 25 μm

Journal: Molecular Brain

Article Title: Ubiquilin-2 drives NF-κB activity and cytosolic TDP-43 aggregation in neuronal cells

doi: 10.1186/s13041-015-0162-6

Figure Lengend Snippet: hUBQLN2 co-localized with TDP-43 and P62 but not with NF-κB and IκB-α. Immunofluorescence of Neuro2A cells at 48 h after transfection with ( a ) control plasmid, ( b ) pCMV-hUBQLN2 WT and ( c ) pCMV-hUBQLN2 P497H . Indicated antibodies were used according to Materials and Methods. Microscopy pictures were taken at 63× magnification. d - e Western analysis from three repeated experiments was used for quantification of ( d ) TDP-43 level ( p = 0.0227 for hUBQLN2 WT and p = 0.0032 for hUBQLN2 P497H ) and ( e ) p62 level ( p = 0.0058 for hUBQLN2 WT and p = 0.0130 for hUBQLN2 P497H ) in insoluble fraction. Results were calculated in fold change compared to proteins level in insoluble fraction of control cells. f Neuro2A cells were transfected with control plasmid, pCMV-hUBQLN2 WT or pCMV-hUBQLN2 P497H . Cells were extracted 48 h after transfection using aggregates assay protocol. The results suggested that overexpression of UBQLN2 species increased levels of UBQLN2, TDP-43 and p62 in the insoluble fraction. g Live imaging was performed on Neuro2A pFeGFP-hUBQLN2 P497H and DsRED-TDP-43 co-transfected cells. Microscopy pictures were taken at 24 and 48 h after transfection. h Immunoblot of TDP-43 in cytoplasmic (C) vs nuclear (N) after transfection with control plasmid, pCMV-hUBQLN2 WT or pCMV-hUBQLN2 P497H plasmids. i HEK293 cells and Neuro2A cells were transfected with either control plasmid or pCMV-hUBQLN2 P497H plasmid. Protein levels of hUBQLN2 and mUBQLN2 were measured at 48 h after transfection. Human UBQLN2 levels were similar in control HEK293 and pCMV-hUBQLN2 P497H Neuro2A transfected cells. Scale bar = 25 μm

Article Snippet: Primary antibodies were monoclonal Flag M2 (Sigma-Aldrich, Saint-Louis, 1:100), TARDBP (Proteintech, Chicago, 1:600), NF-κB p65 (Santa-Cruz, 1:200), IκB-α (Santa-Cruz, 1:200) and SQSTM1/P62 (Cell signaling, 1:200).

Techniques: Immunofluorescence, Transfection, Control, Plasmid Preparation, Microscopy, Western Blot, Over Expression, Imaging

(A) Schematic of the overall design of the study. (B-C) Genomic location profiling of TDP-43 and dG4 in K562 and HepG2 cell lines. (D-E) Genomic location profiling of sites with TDP-43 and dG4 co-occupancy. (F) Overlap of genes with promoter TDP-43 binding and genes with promoter dG4 formation in K562 and HepG2 cells. (G-H) Genome browser view of dG4 and TDP-43 signals across the promoters of TAL1 in K562 cells, and DBF4 in HepG2 cells.

Journal: bioRxiv

Article Title: TDP-43 regulates chromatin looping and gene transcription through binding and stabilizing DNA G-quadruplex structures

doi: 10.64898/2026.05.13.724493

Figure Lengend Snippet: (A) Schematic of the overall design of the study. (B-C) Genomic location profiling of TDP-43 and dG4 in K562 and HepG2 cell lines. (D-E) Genomic location profiling of sites with TDP-43 and dG4 co-occupancy. (F) Overlap of genes with promoter TDP-43 binding and genes with promoter dG4 formation in K562 and HepG2 cells. (G-H) Genome browser view of dG4 and TDP-43 signals across the promoters of TAL1 in K562 cells, and DBF4 in HepG2 cells.

Article Snippet: The following dilutions were used for each antibody: TDP-43 (ABclonal, A1183, 1:1000), H3(Santa Cruz Biotechnology, sc-517576, 1:500); and the secondary antibodies: HRP-conjugated Goat anti-Rabbit IgG (ABclonal, AS014, 1:2000), HRP-conjugated Goat anti-Mouse IgG (ABclonal, AS003, 1:2000).

Techniques: Binding Assay

(A) Schematic of the analysis combining RNA-seq datasets in K562 and HepG2 cells with shNC or shTDP-43 knockdown and dG4 and TDP-43 ChIP-seq datasets. (B) Pie charts of DEGs with promoter TDP-43 binding in shNC vs shTDP-43 K562 and HepG2 cells overlapping with promoter dG4 peaks. (C) Heatmaps of DEGs with promoter TDP-43/dG4 in K562 and HepG2 cells. (D-E) GO term analysis of up-regulated and down-regulated DEGs with promoter TDP-43/dG4 targets in K562 and HepG2 cells. (F-G) Snapshots of TDP-43 and dG4 signals across KIF4, EIF2D promoters in K562 cells and CDC42 , MCM4 promoters in HepG2 cells.

Journal: bioRxiv

Article Title: TDP-43 regulates chromatin looping and gene transcription through binding and stabilizing DNA G-quadruplex structures

doi: 10.64898/2026.05.13.724493

Figure Lengend Snippet: (A) Schematic of the analysis combining RNA-seq datasets in K562 and HepG2 cells with shNC or shTDP-43 knockdown and dG4 and TDP-43 ChIP-seq datasets. (B) Pie charts of DEGs with promoter TDP-43 binding in shNC vs shTDP-43 K562 and HepG2 cells overlapping with promoter dG4 peaks. (C) Heatmaps of DEGs with promoter TDP-43/dG4 in K562 and HepG2 cells. (D-E) GO term analysis of up-regulated and down-regulated DEGs with promoter TDP-43/dG4 targets in K562 and HepG2 cells. (F-G) Snapshots of TDP-43 and dG4 signals across KIF4, EIF2D promoters in K562 cells and CDC42 , MCM4 promoters in HepG2 cells.

Article Snippet: The following dilutions were used for each antibody: TDP-43 (ABclonal, A1183, 1:1000), H3(Santa Cruz Biotechnology, sc-517576, 1:500); and the secondary antibodies: HRP-conjugated Goat anti-Rabbit IgG (ABclonal, AS014, 1:2000), HRP-conjugated Goat anti-Mouse IgG (ABclonal, AS003, 1:2000).

Techniques: RNA Sequencing, Knockdown, ChIP-sequencing, Binding Assay

(A) Volcano plot showing differentially expressed genes in K562 cells with shTDP-43 vs shNC. (B) GO analysis of the up and (C) down genes in (A) . (D) Volcano plot showing differentially expressed genes in HepG2 cells with shTDP-43 vs shNC. (E) GO analysis of the up and (F) down genes in (D) . (G) Volcano plot showing differentially expressed genes with or without TDP-43 binding in K562 cells. (H) GO analysis of the up and (I) down genes with TDP-43 binding in K562 cells with shTDP-43 treatment. (J) Volcano plot showing differentially expressed genes with or without TDP-43 binding in HepG2 cells. (K) GO analysis of the up and (L) down genes with TDP-43 binding in HepG2 cells with shTDP-43.

Journal: bioRxiv

Article Title: TDP-43 regulates chromatin looping and gene transcription through binding and stabilizing DNA G-quadruplex structures

doi: 10.64898/2026.05.13.724493

Figure Lengend Snippet: (A) Volcano plot showing differentially expressed genes in K562 cells with shTDP-43 vs shNC. (B) GO analysis of the up and (C) down genes in (A) . (D) Volcano plot showing differentially expressed genes in HepG2 cells with shTDP-43 vs shNC. (E) GO analysis of the up and (F) down genes in (D) . (G) Volcano plot showing differentially expressed genes with or without TDP-43 binding in K562 cells. (H) GO analysis of the up and (I) down genes with TDP-43 binding in K562 cells with shTDP-43 treatment. (J) Volcano plot showing differentially expressed genes with or without TDP-43 binding in HepG2 cells. (K) GO analysis of the up and (L) down genes with TDP-43 binding in HepG2 cells with shTDP-43.

Article Snippet: The following dilutions were used for each antibody: TDP-43 (ABclonal, A1183, 1:1000), H3(Santa Cruz Biotechnology, sc-517576, 1:500); and the secondary antibodies: HRP-conjugated Goat anti-Rabbit IgG (ABclonal, AS014, 1:2000), HRP-conjugated Goat anti-Mouse IgG (ABclonal, AS003, 1:2000).

Techniques: Binding Assay

(A) TDP-43 and dG4 signal comparison of loop anchors and surrounding regions in K562 cells, the statistical significance was calculated by Mann-Whitney U test, p = 7.23 × 10 -07 for TDP-43 signal, p =1.07 × 10 -10 for dG4 signal. (B) TDP-43 and dG4 signal comparison in HepG2 cells, the statistical significance was calculated by Mann-Whitney U test, p < 2.22 × 10 -16 for TDP-43 signal and dG4 signal. (C) TDP-43 bound loop anchors overlaps with dG4 in K562 and HepG2 cells. (D) Correlation of TDP-43 and dG4 signal at TDP-43+/dG4+ loop anchors in K562 and HepG2 cells. (E) Number of loop anchors with dG4 formation overlapping with TDP-43 in K562 and HepG2 cell lines. (F) Comparison of dG4 signal at dG4-formed loop anchors with or without TDP-43 binding, the statistical significance was calculated by Mann-Whitney U test. (G) Genome browser view of TDP-43, dG4 and Hi-C signals across the promoters of SF3B5 (K562 cell) and COMMD3 (HepG2 cell).

Journal: bioRxiv

Article Title: TDP-43 regulates chromatin looping and gene transcription through binding and stabilizing DNA G-quadruplex structures

doi: 10.64898/2026.05.13.724493

Figure Lengend Snippet: (A) TDP-43 and dG4 signal comparison of loop anchors and surrounding regions in K562 cells, the statistical significance was calculated by Mann-Whitney U test, p = 7.23 × 10 -07 for TDP-43 signal, p =1.07 × 10 -10 for dG4 signal. (B) TDP-43 and dG4 signal comparison in HepG2 cells, the statistical significance was calculated by Mann-Whitney U test, p < 2.22 × 10 -16 for TDP-43 signal and dG4 signal. (C) TDP-43 bound loop anchors overlaps with dG4 in K562 and HepG2 cells. (D) Correlation of TDP-43 and dG4 signal at TDP-43+/dG4+ loop anchors in K562 and HepG2 cells. (E) Number of loop anchors with dG4 formation overlapping with TDP-43 in K562 and HepG2 cell lines. (F) Comparison of dG4 signal at dG4-formed loop anchors with or without TDP-43 binding, the statistical significance was calculated by Mann-Whitney U test. (G) Genome browser view of TDP-43, dG4 and Hi-C signals across the promoters of SF3B5 (K562 cell) and COMMD3 (HepG2 cell).

Article Snippet: The following dilutions were used for each antibody: TDP-43 (ABclonal, A1183, 1:1000), H3(Santa Cruz Biotechnology, sc-517576, 1:500); and the secondary antibodies: HRP-conjugated Goat anti-Rabbit IgG (ABclonal, AS014, 1:2000), HRP-conjugated Goat anti-Mouse IgG (ABclonal, AS003, 1:2000).

Techniques: Comparison, MANN-WHITNEY, Binding Assay, Hi-C

(A) Number of TDP-43+/dG4+, TDP-43+/dG4-, TDP-43-/dG4+ and TDP-43-/dG4-loops in K562 and HepG2 cells. (B) Interaction frequency comparison of above four types of loops in K562 and HepG2 cells. (C) Count of genes whose promoter located at the above four type loop anchors in K562 and HepG2 cells. (D) Expression level of the genes in (C) in K562 and HepG2 cells. (E) Comparison of ATAC-seq signal, (F) H3K4me3 signal, and (G) TF binding events of gene promoters in (C) in K562 and HepG2 cells. The statistical significance in (B), (D), (E), (F), (G) was calculated by Mann-Whitney U test, p-values were shown in the figures.

Journal: bioRxiv

Article Title: TDP-43 regulates chromatin looping and gene transcription through binding and stabilizing DNA G-quadruplex structures

doi: 10.64898/2026.05.13.724493

Figure Lengend Snippet: (A) Number of TDP-43+/dG4+, TDP-43+/dG4-, TDP-43-/dG4+ and TDP-43-/dG4-loops in K562 and HepG2 cells. (B) Interaction frequency comparison of above four types of loops in K562 and HepG2 cells. (C) Count of genes whose promoter located at the above four type loop anchors in K562 and HepG2 cells. (D) Expression level of the genes in (C) in K562 and HepG2 cells. (E) Comparison of ATAC-seq signal, (F) H3K4me3 signal, and (G) TF binding events of gene promoters in (C) in K562 and HepG2 cells. The statistical significance in (B), (D), (E), (F), (G) was calculated by Mann-Whitney U test, p-values were shown in the figures.

Article Snippet: The following dilutions were used for each antibody: TDP-43 (ABclonal, A1183, 1:1000), H3(Santa Cruz Biotechnology, sc-517576, 1:500); and the secondary antibodies: HRP-conjugated Goat anti-Rabbit IgG (ABclonal, AS014, 1:2000), HRP-conjugated Goat anti-Mouse IgG (ABclonal, AS003, 1:2000).

Techniques: Comparison, Expressing, Binding Assay, MANN-WHITNEY

(A) GO term enrichment analysis of genes at dG4+/TDP-43+ loop anchors in K562 and ( B ) HepG2 cells. (C) The proportion of up- or down-regulated genes at different types of loop anchors in K562 and ( D ) HepG2 cells. (E) GO term enrichment analysis of down-regulated genes at dG4+/TDP-4+ loop anchors in K562 and ( F ) HepG2 cells.

Journal: bioRxiv

Article Title: TDP-43 regulates chromatin looping and gene transcription through binding and stabilizing DNA G-quadruplex structures

doi: 10.64898/2026.05.13.724493

Figure Lengend Snippet: (A) GO term enrichment analysis of genes at dG4+/TDP-43+ loop anchors in K562 and ( B ) HepG2 cells. (C) The proportion of up- or down-regulated genes at different types of loop anchors in K562 and ( D ) HepG2 cells. (E) GO term enrichment analysis of down-regulated genes at dG4+/TDP-4+ loop anchors in K562 and ( F ) HepG2 cells.

Article Snippet: The following dilutions were used for each antibody: TDP-43 (ABclonal, A1183, 1:1000), H3(Santa Cruz Biotechnology, sc-517576, 1:500); and the secondary antibodies: HRP-conjugated Goat anti-Rabbit IgG (ABclonal, AS014, 1:2000), HRP-conjugated Goat anti-Mouse IgG (ABclonal, AS003, 1:2000).

Techniques:

(A) Scheme of dG4 CUT&Tag and Micro-C sequencing of HepG2 cells transfected with siNC or siTDP-43 oligos. (B) Western blot of TDP-43 with HepG2 cells transfected with siNC or siTDP-43 oligos. H3 was used as the loading control. (C) dG4 peaks in HepG2 cells transfected with siNC or siTDP-43 oligos. (D) Genome location profiling of dG4 peaks in HepG2 cells transfected with siNC or siTDP-43 oligos. (E) Overlapping of dG4 peaks identified in HepG2 cells transfected with siNC or siTDP-43 oligos. (F) dG4 signals across TDP43/dG4 peaks in HepG2 cells transfected with siNC or siTDP-43 oligos; the statistical significance was calculated by Mann-Whitney U test, p < 2.2 × 10 -16 . (G) Number of TDP-43+/dG4+ loops and other loops identified by Micro-C in siNC HepG2 cells. (H) APA score of TDP-43+/dG4+ loops in (H) in HepG2 cells transfected with siNC or siTDP-43 oligos. (I) Volcano plot of differential interactions of TDP-43+/dG4+ bins in siTDP-43 vs siNC HepG2 cells. (J) Heatmap plot of DEGs located at decreased TDP-43+/dG4+ bins in siTDP-43 vs siNC HepG2 cells. (K) Snapshot of TDP-43 ChIP-seq, H3K27ac ChIP-seq, dG4 CUT&tag, RNA-seq and Micro-C signals across the MCM8 promoter in HepG2 cells transfected with siNC or siTDP-43 oligos. (L) Schematic illustration of the model that TDP-43 loss disrupted dG4 formation, impairs chromatin looping and gene transcription.

Journal: bioRxiv

Article Title: TDP-43 regulates chromatin looping and gene transcription through binding and stabilizing DNA G-quadruplex structures

doi: 10.64898/2026.05.13.724493

Figure Lengend Snippet: (A) Scheme of dG4 CUT&Tag and Micro-C sequencing of HepG2 cells transfected with siNC or siTDP-43 oligos. (B) Western blot of TDP-43 with HepG2 cells transfected with siNC or siTDP-43 oligos. H3 was used as the loading control. (C) dG4 peaks in HepG2 cells transfected with siNC or siTDP-43 oligos. (D) Genome location profiling of dG4 peaks in HepG2 cells transfected with siNC or siTDP-43 oligos. (E) Overlapping of dG4 peaks identified in HepG2 cells transfected with siNC or siTDP-43 oligos. (F) dG4 signals across TDP43/dG4 peaks in HepG2 cells transfected with siNC or siTDP-43 oligos; the statistical significance was calculated by Mann-Whitney U test, p < 2.2 × 10 -16 . (G) Number of TDP-43+/dG4+ loops and other loops identified by Micro-C in siNC HepG2 cells. (H) APA score of TDP-43+/dG4+ loops in (H) in HepG2 cells transfected with siNC or siTDP-43 oligos. (I) Volcano plot of differential interactions of TDP-43+/dG4+ bins in siTDP-43 vs siNC HepG2 cells. (J) Heatmap plot of DEGs located at decreased TDP-43+/dG4+ bins in siTDP-43 vs siNC HepG2 cells. (K) Snapshot of TDP-43 ChIP-seq, H3K27ac ChIP-seq, dG4 CUT&tag, RNA-seq and Micro-C signals across the MCM8 promoter in HepG2 cells transfected with siNC or siTDP-43 oligos. (L) Schematic illustration of the model that TDP-43 loss disrupted dG4 formation, impairs chromatin looping and gene transcription.

Article Snippet: The following dilutions were used for each antibody: TDP-43 (ABclonal, A1183, 1:1000), H3(Santa Cruz Biotechnology, sc-517576, 1:500); and the secondary antibodies: HRP-conjugated Goat anti-Rabbit IgG (ABclonal, AS014, 1:2000), HRP-conjugated Goat anti-Mouse IgG (ABclonal, AS003, 1:2000).

Techniques: Sequencing, Transfection, Western Blot, Control, MANN-WHITNEY, ChIP-sequencing, RNA Sequencing